Can We Decide Which Outcomes Should Be Measured in Every Clinical Trial? A Scoping Review of the Existing Conceptual Frameworks and Processes to Develop Core Outcome Sets

被引:43
作者
Idzerda, Leanne [1 ]
Rader, Tamara [1 ]
Tugwell, Peter [2 ]
Boers, Maarten [3 ]
机构
[1] Univ Ottawa, Inst Populat Hlth, Ctr Global Hlth Res, Ottawa, ON, Canada
[2] Univ Ottawa, Dept Med, Ottawa, ON, Canada
[3] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands
关键词
OUTCOME AND PROCESS ASSESSMENT; CORE OUTCOME SETS; CLINICAL TRIALS; OMERACT; 11; CONSENSUS DEVELOPMENT PROJECT; VERSUS-HOST-DISEASE; END-POINTS; DEFINITIONS; CRITERIA; PROPOSAL; CANCER;
D O I
10.3899/jrheum.131308
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The usefulness of randomized control trials to advance clinical care depends upon the outcomes reported, but disagreement on the choice of outcome measures has resulted in inconsistency and the potential for reporting bias. One solution to this problem is the development of a core outcome set: a minimum set of outcome measures deemed critical for clinical decision making. Within rheumatology the Outcome Measures in Rheumatology (OMERACT) initiative has pioneered the development of core outcome sets since 1992. As the number of diseases addressed by OMERACT has increased and its experience in formulating core sets has grown, clarification and update of the conceptual framework and formulation of a more explicit process of area/domain core set development has become necessary. As part of the update process of the OMERACT Filter criteria to version 2, a literature review was undertaken to compare and contrast the OMERACT conceptual framework with others within and outside rheumatology. Methods. A scoping search was undertaken to examine the extent, range, and nature of conceptual frameworks for core set outcome selection in health. We searched the following resources: Cochrane Library Methods Group Register; Medline; Embase; PsycInfo; Environmental Studies and Policy Collection; and ABI/INFORM Global. We also conducted a targeted Google search. Results. Five conceptual frameworks were identified: the WHO tripartite definition of health; the 5 Ds (discomfort, disability, drug toxicity, dollar cost, and death); the International Classification of Functioning (ICF); PROMIS (Patient-Reported Outcomes Measurement System); and the Outcomes Hierarchy. Of these, only the 5 Ds and ICF frameworks have been systematically applied in core set development. Outside the area of rheumatology, several core sets were identified; these had been developed through a limited range of consensus-based methods with varying degrees of methodological rigor. None applied a framework to ensure content validity of the end product. Conclusion. This scoping review reinforced the need for clear methods and standards for core set development. Based on these findings, OMERACT will make its own conceptual framework and working process more explicit. Proposals for how to achieve this were discussed at the OMERACT 11 conference.
引用
收藏
页码:986 / 993
页数:8
相关论文
共 36 条
[1]  
[Anonymous], 2002, ICF beginner's guide: towards a common language for functioning, disability and health
[2]   Systematic review of health-related quality of life models [J].
Bakas, Tamilyn ;
McLennon, Susan M. ;
Carpenter, Janet S. ;
Buelow, Janice M. ;
Otte, Julie L. ;
Hanna, Kathleen M. ;
Ellett, Marsha L. ;
Hadler, Kimberly A. ;
Welch, Janet L. .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2012, 10
[3]   Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group [J].
Bellomo, R ;
Ronco, C ;
Kellum, JA ;
Mehta, RL ;
Palevsky, P .
CRITICAL CARE, 2004, 8 (04) :R204-R212
[4]  
Boers M, 1998, J RHEUMATOL, V25, P198
[5]   Toward a Generalized Framework of Core Measurement Areas in Clinical Trials: A Position Paper for OMERACT 11 [J].
Boers, Maarten ;
Idzerda, Leanne ;
Kirwan, John R. ;
Beaton, Dorcas ;
Escorpizo, Reuben ;
Boonen, Annelies ;
Magasi, Susan ;
Sinha, Ian ;
Stucki, Gerold ;
Tugwell, Peter .
JOURNAL OF RHEUMATOLOGY, 2014, 41 (05) :978-985
[7]  
Capell H, 2002, J RHEUMATOL, V29, P2099
[8]   Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: Report of a consensus conference [J].
Carlson, GA ;
Jensen, PS ;
Findling, RL ;
Meyer, RE ;
Calabrese, J ;
DelBello, MP ;
Emslie, G ;
Flynn, L ;
Goodwin, F ;
Hellander, M ;
Kowatch, R ;
Kusumakar, V ;
Laughren, T ;
Leibenluft, E ;
McCracken, J ;
Nottelmann, E ;
Pine, D ;
Sachs, G ;
Shaffer, D ;
Simar, R ;
Strober, M ;
Weller, EB ;
Wozniak, J ;
Youngstrom, EA .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (01) :13-27
[9]   The Patient-Reported Outcomes Measurement Information System (PROMIS) Progress of an NIH roadmap cooperative group during its first two years [J].
Cella, David ;
Yount, Susan ;
Rothrock, Nan ;
Gershon, Richard ;
Cook, Karon ;
Reeve, Bryce ;
Ader, Deborah ;
Fries, James F. ;
Bruce, Bonnie ;
Rose, Mattias .
MEDICAL CARE, 2007, 45 (05) :S3-S11
[10]   Development of ICF core sets for patients with chronic conditions [J].
Cieza, A ;
Ewert, T ;
Üstün, TB ;
Chatterji, S ;
Kostanjsek, N ;
Stucki, G .
JOURNAL OF REHABILITATION MEDICINE, 2004, 36 :9-11